Tschiedel E, Assert R, Felderhoff-Müser U, Kathemann S, Witzke O, Hoyer P, Dohna-Schwake C

Language: English
References: 27
Page: 631-637
PDF size: 184.75 Kb.

ABSTRACT

Introduction and aim. Procalcitonin is widely used as a biomarker to distinguish bacterial infections from other etiologies of systemic inflammation. Little is known about its value in acute liver injury resulting from intoxication with paracetamol. Material and methods. We performed a single-center retrospective analysis of the procalcitonin level, liver synthesis, liver cell damage and renal function of patients admitted with paracetamol-induced liver injury to a tertiary care children’s hospital. Children with acute liver failure due to other reasons without a bacterial or fungal infection served as the control group. Twelve patients with acute paracetamol intoxication and acute liver injury were compared with 29 patients with acute liver failure. Results. The procalcitonin levels were higher in children with paracetamol intoxication than in patients with acute liver failure without paracetamol intoxication (median 24.8 (0.01-55.57) ng/mL vs. 1.36 (0.1-44.18) ng/mL; p ‹ 0.005), although their liver and kidney functions were better and the liver cell injury was similar in both groups. Outcome analysis showed a trend towards better survival without transplantation in patients with paracetamol intoxication (10/12 vs. 15/29). Within each group, procalcitonin was significantly correlated with alanine aminotransferase and aspartate aminotransferase but was not correlated with the International Normalized Ratio or paracetamol blood levels in the paracetamol group. In conclusion, paracetamol intoxication leads to a marked increase in procalcitonin serum levels, which are significantly higher than those seen in acute liver failure. Conclusion. The underlying mechanism is neither caused by infection nor fully explained by liver cell death alone and remains to be determined.

REFERENCES

1. Weglöhner W, Struck J, Fischer-Schulz C, Morgenthaler NG, Otto A, Bohuon C, Bergmann A. Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 2001; 12: 2099-103.

2. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341(8844): 515-18

3. Baer G, Baumann P, Buettcher M, Heininger U, Berthet G, Schäfer J, Bucher HC, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (PROPAED): a randomized controlled trial. Plos One 2013; 8: e68419.

4. Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P, Prieto B. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007; 33: 477-84.

5. Cies JJ, Chopra A. Procalcitonin use in a pediatric intensive care unit. Pediatr Infect Dis J 2014; 33: 984-6.

6. Haeussler GM, Carlesse F, Phillipps RS. An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer. Pediatr Infect Dis J 2013; 32: e3990-e396.

7. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458-61.

8. Kretzschmar M, Kruger A, Schirrmeister W. Procalcitonin following elective partial liver resection – origin from the liver? Acta Anaesthesiol Scand 2001; 45: 1162-7.

9. Brodska H, Drabek T, Malickova K, Kazda A, Vitek A, Zima T, Markova M. Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study. Critical Care 2009; 13: R37.

10. Davidson J, Tong S, Hauck A, Lawson DS, da Cruz E, Kaufman J. Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery. Pediatr Res 2013; 74: 413-19.

11. Dauber A, Weiss S, Maniaci V, Nylen E, Becker KL, Bachur R. Procalcitonin levels in febrile infants after recent immunization. Pediatrics 2008; 122: e1119-e1122.

12. Minami E, Ito S, Sugiura T, Fujita Y, Sasano H, Sobue K. Markedly elevated procalcitonin in early postoperative period in pediatric open heart surgery: a prospective cohort study. J Intensive Care 2014; 2: 38.

13. Rey C, García-Hernández I, Concha A, Martínez-Camblor P, Botrán M, Medina A, Prieto B, et al. Pro-adrenomedullin, proendothelin- 1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study. Crit Care 2013; 17: R240.

14. Sugihara T, Koda M, Okamoto T, Miyoshi K, Matono T, Oyama KH, Okano J, et al. Serum Procalcitonin in Patients with acute liver failure. Yonago Acta Med 2017; 60: 40-6.

15. Rule JA, Hynan LS, Attar N, Sanders C, Corzun WJ, Lee WM. Acute liver failure study group. Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure. Plos One 2015; 10: e0138566.

16. Mallet M, Haq M, Tripon S, Bernard M, Benosman H, Thabut D, Rudler M. Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication. Eur J Gastroenterol Hepatol 2017; 29: 811-16.

17. Patout M, Salaün M, Brunel V, Bota S, Cauliez B, Thiberville L. Diagnostic and prognostic value of serumprocalcitonin concentrations in primary lung cancers. Clin Biochem 2014; 47: 263-7.

18. Shen H, Zheng S, Chen R, Jin X, Xu X, Jing C, Lin J, et al. Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization. A retrospective analysis of 509 cases. Medicine 2017; 96: 28(e7438).

19. Zant R, Melter M, Knoppke B, Ameres M, Kunkel J. Kinetics of interleukin-6, procalcitonin, and C-reactive protein after pediatric liver transplantation. Transplant Proc 2014; 46: 3507- 10.

20. Zant R, Melter M, Schlitt HJ, Loss M, Ameres M, Knoppke B, Kunkel J. High levels of procalcitonin in the early phase after pediatric liver transplantation indicate poor postoperative outcome. Hepatogastroenterology 2014; 61: 1344-9.

21. Jackson N, Batouche S, Shrewood R, Wendon J. Serial plasma procalcitonin levels in patients requiring admission to liver ICU with paracetamol induced acute liver failure. Br J Anesthesia 2000; 84: 692P.

22. Turan H, Horasanli B, Ugur M, Arslan H. Procalcitonin levels in migraine patients. Can J Neurol Sci 2011; 38: 124-8.

23. Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012; 8-20.

24. Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 2015; 12: 387-400.

25. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol 2016; 4: 131-42.

26. Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, Rimm EB, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006; 113: 1578-87.

27. Chiam E, Weinberg L, Bellomo R. Paracetamol: a review with specific focus on the haemodynamic effects of intravenous administration. Heart Lung Vessel 2015; 7: 121-32.